Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
GLP-1-receptoragonisten verlagen mogelijk het risico op epilepsie bij DM2
mrt 2026 | Diabetes, Epilepsie